nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—RARB—head and neck cancer	0.886	1	CbGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—RARB—head and neck cancer	0.00377	0.0458	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—RARB—head and neck cancer	0.00336	0.0409	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RARB—head and neck cancer	0.00324	0.0394	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—RARB—head and neck cancer	0.00324	0.0394	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00304	0.037	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—RARB—head and neck cancer	0.00289	0.0351	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—RARB—head and neck cancer	0.00289	0.0351	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—RARB—head and neck cancer	0.00278	0.0338	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00262	0.0318	CbGpPWpGaD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.00252	0.0306	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—RARB—head and neck cancer	0.00239	0.0291	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—RARB—head and neck cancer	0.00239	0.0291	CbGpPWpGaD
Tazarotene—RXRB—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00236	0.0287	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.0022	0.0267	CbGpPWpGaD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.00217	0.0263	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.00217	0.0263	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00189	0.023	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00189	0.023	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00185	0.0617	CcSEcCtD
Tazarotene—Skin irritation—Fluorouracil—head and neck cancer	0.00183	0.0611	CcSEcCtD
Tazarotene—Application site pain—Fluorouracil—head and neck cancer	0.0018	0.0601	CcSEcCtD
Tazarotene—Blister—Hydroxyurea—head and neck cancer	0.00153	0.0509	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00133	0.0444	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.00121	0.0147	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—CEBPA—head and neck cancer	0.00115	0.014	CbGpPWpGaD
Tazarotene—Blister—Fluorouracil—head and neck cancer	0.0011	0.0366	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.00108	0.0132	CbGpPWpGaD
Tazarotene—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00105	0.035	CcSEcCtD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.00104	0.0126	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—BCL2—head and neck cancer	0.00104	0.0126	CbGpPWpGaD
Tazarotene—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00102	0.0124	CbGpPWpGaD
Tazarotene—Stinging—Fluorouracil—head and neck cancer	0.000977	0.0326	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.000961	0.0321	CcSEcCtD
Tazarotene—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000928	0.0113	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—STAT6—head and neck cancer	0.00092	0.0112	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.000836	0.0279	CcSEcCtD
Tazarotene—Burning sensation—Docetaxel—head and neck cancer	0.000823	0.0274	CcSEcCtD
Tazarotene—Inflammation—Fluorouracil—head and neck cancer	0.000816	0.0272	CcSEcCtD
Tazarotene—Dermatitis contact—Fluorouracil—head and neck cancer	0.000783	0.0261	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—CDH1—head and neck cancer	0.000772	0.00937	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—MAPK3—head and neck cancer	0.000763	0.00927	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—MAPK1—head and neck cancer	0.000726	0.00882	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—MAPK3—head and neck cancer	0.000685	0.00831	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000658	0.00799	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK3—head and neck cancer	0.000656	0.00797	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—MAPK3—head and neck cancer	0.000656	0.00797	CbGpPWpGaD
Tazarotene—Swelling—Fluorouracil—head and neck cancer	0.000652	0.0217	CcSEcCtD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—MAPK1—head and neck cancer	0.000651	0.00791	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—MAPK1—head and neck cancer	0.000624	0.00758	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK1—head and neck cancer	0.000624	0.00758	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000624	0.00758	CbGpPWpGaD
Tazarotene—Haemoglobin—Vinblastine—head and neck cancer	0.000609	0.0203	CcSEcCtD
Tazarotene—Haemorrhage—Vinblastine—head and neck cancer	0.000606	0.0202	CcSEcCtD
Tazarotene—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000601	0.0201	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000599	0.00727	CbGpPWpGaD
Tazarotene—Inflammation—Docetaxel—head and neck cancer	0.000589	0.0197	CcSEcCtD
Tazarotene—Haemoglobin—Hydroxyurea—head and neck cancer	0.000555	0.0185	CcSEcCtD
Tazarotene—Haemorrhage—Hydroxyurea—head and neck cancer	0.000552	0.0184	CcSEcCtD
Tazarotene—Skin exfoliation—Docetaxel—head and neck cancer	0.000546	0.0182	CcSEcCtD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000544	0.00661	CbGpPWpGaD
Tazarotene—Dry skin—Fluorouracil—head and neck cancer	0.000527	0.0176	CcSEcCtD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.000515	0.00625	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.00049	0.00595	CbGpPWpGaD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000488	0.00593	CbGpPWpGaD
Tazarotene—Erythema—Hydroxyurea—head and neck cancer	0.000481	0.016	CcSEcCtD
Tazarotene—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000471	0.00572	CbGpPWpGaD
Tazarotene—Swelling—Docetaxel—head and neck cancer	0.00047	0.0157	CcSEcCtD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000468	0.00569	CbGpPWpGaD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000468	0.00569	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.000462	0.00561	CbGpPWpGaD
Tazarotene—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000453	0.0151	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—head and neck cancer	0.000451	0.00548	CbGpPWpGaD
Tazarotene—Discomfort—Vinblastine—head and neck cancer	0.000444	0.0148	CcSEcCtD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.000443	0.00538	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—AKT1—head and neck cancer	0.000443	0.00538	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Docetaxel—head and neck cancer	0.000434	0.0145	CcSEcCtD
Tazarotene—RARG—tongue—head and neck cancer	0.000412	0.212	CbGeAlD
Tazarotene—Discomfort—Hydroxyurea—head and neck cancer	0.000405	0.0135	CcSEcCtD
Tazarotene—Haemoglobin—Fluorouracil—head and neck cancer	0.0004	0.0133	CcSEcCtD
Tazarotene—Haemorrhage—Fluorouracil—head and neck cancer	0.000398	0.0133	CcSEcCtD
Tazarotene—Oedema—Hydroxyurea—head and neck cancer	0.000393	0.0131	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—head and neck cancer	0.000392	0.00476	CbGpPWpGaD
Tazarotene—Dry skin—Docetaxel—head and neck cancer	0.00038	0.0127	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—RARB—head and neck cancer	0.00038	0.00462	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000375	0.00455	CbGpPWpGaD
Tazarotene—Pain—Vinblastine—head and neck cancer	0.000368	0.0123	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—head and neck cancer	0.000362	0.0044	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000359	0.00437	CbGpPWpGaD
Tazarotene—Erythema—Fluorouracil—head and neck cancer	0.000346	0.0115	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—YAP1—head and neck cancer	0.000346	0.0042	CbGpPWpGaD
Tazarotene—Pain—Hydroxyurea—head and neck cancer	0.000336	0.0112	CcSEcCtD
Tazarotene—RARA—Generic Transcription Pathway—RARB—head and neck cancer	0.000327	0.00397	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—RARB—head and neck cancer	0.000327	0.00397	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—head and neck cancer	0.00032	0.00389	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—YAP1—head and neck cancer	0.00031	0.00377	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—YAP1—head and neck cancer	0.000297	0.00361	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—YAP1—head and neck cancer	0.000297	0.00361	CbGpPWpGaD
Tazarotene—Discomfort—Fluorouracil—head and neck cancer	0.000291	0.00971	CcSEcCtD
Tazarotene—Haemoglobin—Docetaxel—head and neck cancer	0.000288	0.00962	CcSEcCtD
Tazarotene—Haemorrhage—Docetaxel—head and neck cancer	0.000287	0.00957	CcSEcCtD
Tazarotene—Oedema peripheral—Docetaxel—head and neck cancer	0.000283	0.00943	CcSEcCtD
Tazarotene—Oedema—Fluorouracil—head and neck cancer	0.000283	0.00942	CcSEcCtD
Tazarotene—RARG—mouth—head and neck cancer	0.000277	0.143	CbGeAlD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000256	0.00311	CbGpPWpGaD
Tazarotene—Erythema—Docetaxel—head and neck cancer	0.00025	0.00833	CcSEcCtD
Tazarotene—Rash—Hydroxyurea—head and neck cancer	0.000247	0.00826	CcSEcCtD
Tazarotene—Dermatitis—Hydroxyurea—head and neck cancer	0.000247	0.00825	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000246	0.00298	CbGpPWpGaD
Tazarotene—Pain—Fluorouracil—head and neck cancer	0.000242	0.00806	CcSEcCtD
Tazarotene—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000238	0.00289	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000235	0.00286	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.00022	0.00267	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—STAT3—head and neck cancer	0.000213	0.00258	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000211	0.00256	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000209	0.00254	CbGpPWpGaD
Tazarotene—Oedema—Docetaxel—head and neck cancer	0.000204	0.0068	CcSEcCtD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000203	0.00247	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000201	0.00244	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.0002	0.00243	CbGpPWpGaD
Tazarotene—Pruritus—Fluorouracil—head and neck cancer	0.0002	0.00667	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000189	0.00229	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000187	0.00227	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000184	0.00224	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RARB—head and neck cancer	0.000183	0.00222	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000182	0.00221	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000181	0.0022	CbGpPWpGaD
Tazarotene—Rash—Fluorouracil—head and neck cancer	0.000178	0.00594	CcSEcCtD
Tazarotene—Dermatitis—Fluorouracil—head and neck cancer	0.000178	0.00594	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000175	0.00212	CbGpPWpGaD
Tazarotene—Pain—Docetaxel—head and neck cancer	0.000174	0.00582	CcSEcCtD
Tazarotene—RARG—Gene Expression—YAP1—head and neck cancer	0.000166	0.00202	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000165	0.002	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000165	0.002	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000158	0.00192	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RARB—head and neck cancer	0.000157	0.00191	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—RARB—head and neck cancer	0.000157	0.00191	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000156	0.00189	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000156	0.00189	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—YAP1—head and neck cancer	0.000149	0.00181	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000149	0.00181	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000148	0.0018	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000148	0.0018	CbGpPWpGaD
Tazarotene—Pruritus—Docetaxel—head and neck cancer	0.000144	0.00481	CcSEcCtD
Tazarotene—RXRB—Gene Expression—YAP1—head and neck cancer	0.000143	0.00174	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—YAP1—head and neck cancer	0.000143	0.00174	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000142	0.00173	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000142	0.00172	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00014	0.0017	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.00014	0.0017	CbGpPWpGaD
Tazarotene—RARB—thyroid gland—head and neck cancer	0.000138	0.0712	CbGeAlD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000134	0.00163	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000134	0.00163	CbGpPWpGaD
Tazarotene—Rash—Docetaxel—head and neck cancer	0.000129	0.00429	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000129	0.00156	CbGpPWpGaD
Tazarotene—Dermatitis—Docetaxel—head and neck cancer	0.000128	0.00428	CcSEcCtD
Tazarotene—RXRB—thyroid gland—head and neck cancer	0.000127	0.0654	CbGeAlD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000124	0.00151	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000123	0.0015	CbGpPWpGaD
Tazarotene—RARB—head—head and neck cancer	0.000123	0.0632	CbGeAlD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000119	0.00145	CbGpPWpGaD
Tazarotene—RARA—lymphoid tissue—head and neck cancer	0.000117	0.0601	CbGeAlD
Tazarotene—RARG—thyroid gland—head and neck cancer	0.000113	0.0581	CbGeAlD
Tazarotene—RXRB—head—head and neck cancer	0.000113	0.058	CbGeAlD
Tazarotene—RARA—thyroid gland—head and neck cancer	0.000106	0.0546	CbGeAlD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000105	0.00128	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000101	0.00122	CbGpPWpGaD
Tazarotene—RARG—head—head and neck cancer	0.0001	0.0515	CbGeAlD
Tazarotene—RARA—head—head and neck cancer	9.42e-05	0.0484	CbGeAlD
Tazarotene—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	9.24e-05	0.00112	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	9.11e-05	0.00111	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	8.76e-05	0.00106	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	8.64e-05	0.00105	CbGpPWpGaD
Tazarotene—RARB—lymph node—head and neck cancer	8.6e-05	0.0442	CbGeAlD
Tazarotene—CYP2C8—Metabolism—UROD—head and neck cancer	7.7e-05	0.000936	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH1—head and neck cancer	7.5e-05	0.000911	CbGpPWpGaD
Tazarotene—RARG—lymph node—head and neck cancer	7.01e-05	0.0361	CbGeAlD
Tazarotene—RARB—Gene Expression—NOTCH1—head and neck cancer	6.73e-05	0.000817	CbGpPWpGaD
Tazarotene—RARA—lymph node—head and neck cancer	6.59e-05	0.0339	CbGeAlD
Tazarotene—RARA—Gene Expression—NOTCH1—head and neck cancer	6.45e-05	0.000784	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH1—head and neck cancer	6.45e-05	0.000784	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.98e-05	0.000726	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MAPK3—head and neck cancer	4.15e-05	0.000504	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MAPK3—head and neck cancer	3.72e-05	0.000452	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MAPK3—head and neck cancer	3.57e-05	0.000434	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MAPK3—head and neck cancer	3.57e-05	0.000434	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.4e-05	0.000413	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.36e-05	0.000408	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NAT2—head and neck cancer	3.2e-05	0.000388	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DPYD—head and neck cancer	2.8e-05	0.000341	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—head and neck cancer	2.8e-05	0.00034	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—YAP1—head and neck cancer	2.66e-05	0.000323	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—head and neck cancer	2.51e-05	0.000305	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—head and neck cancer	2.41e-05	0.000292	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—head and neck cancer	2.41e-05	0.000292	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2e-05	0.000243	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.74e-05	0.000212	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—TYMS—head and neck cancer	1.6e-05	0.000194	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.58e-05	0.000192	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPX1—head and neck cancer	1.51e-05	0.000184	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.5e-05	0.000182	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.23e-05	0.000149	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—head and neck cancer	8.91e-06	0.000108	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTEN—head and neck cancer	7.77e-06	9.43e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CA—head and neck cancer	5.48e-06	6.65e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—head and neck cancer	4.48e-06	5.44e-05	CbGpPWpGaD
